The use of artificial intelligence in advancing molecular biology in Africa: a narrative review.

Artificial intelligence (AI) is rapidly becoming a core methodological pillar of molecular biology and precision medicine, and Africa is a uniquely consequential setting for this transition because the continent combines the world's greatest human genomic diversity with the most severe underrepresentation of that diversity in the datasets and reference resources on which AI models are built and benchmarked. This narrative review examines, for a genetics and genomics readership, where AI-driven methods are already strengthening African molecular biology, where the supporting evidence remains preliminary, and what is required to translate technical capability into scientifically robust and equitable benefit. The central argument is that AI is especially consequential in African molecular biology, not simply because it automates analysis, but because it can help unlock insight from African genomic diversity, pathogen biology, and clinically relevant multi-omics data that remain underrepresented in global models. Across core molecular domains, AI is accelerating protein structure prediction, high-throughput variant calling and pan-genomic reference construction, genome-wide association analysis, transcriptomic interpretation, drug discovery, and CRISPR guide design. African initiatives such as H3Africa, the African Genome Variation Project, H3ABioNet, and the H3D Centre show that locally generated datasets and African-led computational pipelines can already support meaningful discovery, from improved variant interpretation to structure-guided therapeutic prioritization. At the same time, persistent barriers remain, including underrepresentation of African genomes in training data and reference genomes, uneven computational infrastructure, limited interdisciplinary training, fragmented governance, and the risk that AI-derived benefits will remain inaccessible to the populations whose data enable them. We conclude that the future impact of AI in African molecular biology will depend less on adopting global tools in the abstract and more on building African-led datasets, validation pipelines, governance frameworks, and translational pathways that make molecular discovery both scientifically robust and equitably useful. Looking ahead, the central perspective offered by this review is that Africa's exceptional genomic diversity should be treated as a scientific asset rather than an analytical liability: realising this will require population-representative pan-genome references, sustained computational capacity, and governance structures that ensure African populations are not only the source of the underlying data but also the principal beneficiaries of the discoveries it enables.